The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis.

被引：0
|
作者：
Maetzel, A
Krahn, M
Naglie, G
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1546
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [21] Cost-Effectiveness Analysis Of Two Rituximab Based Therapeutic Regimens For Longstanding Rheumatoid Arthritis.
    Quartuccio, Luca
    Di Bidino, Rossella
    Ruggeri, Matteo
    Biasi, Domenico
    Schiavon, Franco
    Punzi, Leonardo
    Adami, Silvano
    Cicchetti, Americo
    De Vita, Salvatore
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S428 - S428
  • [22] Cost-effectiveness of anakinra plus methotrexate versus methotrexate alone for the treatment of rheumatoid arthritis.
    Guh, DP
    Marra, CA
    Woolcott, JC
    Gignac, M
    Esdaile, JM
    Clarke, A
    Anis, AH
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S264 - S264
  • [23] COST-EFFECTIVENESS OF BIOLOGICAL TREATMENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN TAIWAN
    Chen, H. F.
    Lin, H. Y.
    Lang, H. C.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A673 - A673
  • [24] Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis
    Peng, Kuan
    Chan, Shirley C. W.
    Wang, Yang
    Cheng, Franco W. T.
    Yeung, Winnie W. Y.
    Jiao, Yuanshi
    Chan, Esther W. Y.
    Wong, Ian C. K.
    Lau, Chak-Sing
    Li, Xue
    [J]. JAMA NETWORK OPEN, 2024, 7 (06)
  • [25] Cost-Effectiveness Analysis Of Diagnostic Tests In The Work-Up Of Patients With Intermediate Risk Of Developing Rheumatoid Arthritis.
    Luime, Jolanda J.
    Rutten, Maureen
    Buisman, Leander
    Oppe, Mark
    Hazes, Johanna M. W.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S43 - S43
  • [26] Cost-effectiveness of replacing diclofenac 75 mg BID by celecoxib 200 mg BID in patients with rheumatoid arthritis (RA).
    Kristiansen, IS
    Kvien, TK
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S146 - S146
  • [27] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    Day, R
    Ferraz, MB
    Hawkey, CJ
    Hochberg, MC
    Kvien, TK
    Schnitzer, TJ
    Weaver, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21): : 1520 - 1528
  • [28] Cost-Effectiveness of Systemic Therapies for Acute Gouty Arthritis.
    Reiter, Kimberly
    Goldhaber-Fiebert, Jeremy
    Krishnan, Eswar
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1036 - S1037
  • [29] Cost-effectiveness of rituximab strategies in rheumatoid arthritis
    Seror, Raphaele
    Mariette, Xavier
    [J]. LANCET, 2017, 389 (10067): : 365 - 366
  • [30] Cost-effectiveness of infliximab for rheumatoid arthritis in Spain
    Wong, JB
    Ballina, J
    Fernandez-Sueiro, J
    Garcia-Vadillo, J
    Gonzalez-Fernandez, C
    Gonzalez-Crespo, M
    Gratacos, J
    Ivorra, J
    Navarro-Sarabia, F
    Tornero, J
    Casado, MA
    Fosbrook, L
    Pocovi, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 520 - 521
12345